Variables | Total | SUA, μmol/L | P | Pa | ||
---|---|---|---|---|---|---|
Tertile 1 (< 341.7) | Tertile 2 (≥ 341.7, < 437.0) | Tertile 3 (≥ 437.0) | ||||
N | 475 | 158 | 158 | 159 | ||
Time first symptom/admission, hours | 15.00 (5.00–72.00) | 21.00 (5.00–48.00) | 12.00 (4.25–72.00) | 12.00 (5.00–72.00) | 0.397 | NS |
Time first symptom/SUA, hours | 15.17 (5.29–72.12) | 22.12 (6.02–55.91) | 12.76 (5.18–72.31) | 14.17 (5.27–72.29) | 0.418 | NS |
Time first symptom/LDL-C, hours | 30.08 (15.96–80.31) | 34.00 (16.62–66.64) | 28.48 (15.04–81.61) | 29.12 (17.40–82.99) | 0.385 | NS |
MI type and location, n (%) | 0.857 | |||||
NSTEMI | 133 (28.00%) | 48 (30.38%) | 42 (26.58%) | 43 (27.04%) | NS | |
Anterior STEMI | 144 (30.32%) | 46 (29.11%) | 46 (29.11%) | 52 (32.70%) | NS | |
Non anterior STEMI | 198 (41.68%) | 64 (40.51%) | 70 (44.30%) | 64 (40.25%) | NS | |
Number of diseased vessels, n (%) | 0.524 | |||||
0 | 1 (0.22%) | 1 (0.65%) | 0 (0.00%) | 0 (0.00%) | NS | |
1 | 156 (34.44%) | 56 (36.36%) | 51 (34.69%) | 49 (32.24%) | NS | |
2 | 141 (31.13%) | 49 (31.82%) | 51 (34.69%) | 41 (26.97%) | NS | |
3 | 142 (31.35%) | 45 (29.22%) | 41 (27.89%) | 56 (36.84%) | NS | |
4 | 13 (2.87%) | 3 (1.95%) | 4 (2.72%) | 6 (3.95%) | NS | |
Culprit vessel, n (%) | 0.561 | |||||
LAD | 211 (46.68%) | 65 (42.48%) | 70 (47.62%) | 76 (50.00%) | NS | |
RCA | 149 (32.96%) | 57 (37.25%) | 44 (29.93%) | 48 (31.58%) | NS | |
LCX | 89 (19.69%) | 31 (20.26%) | 31 (21.09%) | 27 (17.76%) | NS | |
LM | 3 (0.66%) | 0 (0.00%) | 2 (1.36%) | 1 (0.66%) | NS | |
LVEF, % | 56.00 (49.00–62.25) | 58.00 (51.25–63.75) | 56.00 (48.00–62.50) | 54.00 (48.00–61.00) | 0.041 | NS |